Figures computed from official regulatory filings — .
Ownershipinsiders 6.71% · institutions 7.8%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ADOCIA only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. The company's proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company provides BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid prandial insulin lispro; BioChaperone GLP-1 Amylin, a combination of acting insulin glargine and rapid-acting insulin lispro, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity, including AdoShell Islets, an ultra rapid insulin; AdOral Sema, an oral form of GLP-1 semaglutide; and AdoXLongSem, a long-lasting injectable formulation of semaglutide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Market information source · Oct 19, 2026
Open-market timeline · full history
6 buys14 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| GERARD SOULA | Buy | $519.9K | conv 41 | AMF | |
| GERARD SOULA | Buy | $543.1K | conv 47 | AMF | |
| Olivier Soula | Buy | $162.9K | conv 64First in 12mo | AMF | |
| GERARD SOULA | Sell | $58.6K | AMF | ||
| GERARD SOULA | Sell | $209.5K | AMF | ||
| GERARD SOULA | Sell | $9.9K | Unusual size | AMF | |
| GERARD SOULA | Sell | $261.1K | AMF | ||
| GERARD SOULA | Sell | $89.1K | AMF | ||
| GERARD SOULA | Sell | $421.9K | AMF | ||
| GERARD SOULA | Sell | $310.3K | AMF | ||
| SYLVIE SOULA | Buy | $1.1M | conv 23First in 12mo | AMF | |
| GERARD SOULA | Sell | $113.9K | AMF | ||
| GERARD SOULA | Buy | $550.9 | conv 50First in 12mo | AMF | |
| GERARD SOULA | Buy | $1.2M | conv 51First in 12mo | AMF | |
| BPIFRANCE INVESTISSEMENT SAStrack record | Sell | $949.7 | AMF | ||
| BPIFRANCE INVESTISSEMENT SAStrack record | Sell | $43K | AMF | ||
| BPIFRANCE INVESTISSEMENT SAStrack record | Sell | $4.8K | AMF | ||
| BPIFRANCE INVESTISSEMENT SAStrack record | Sell | $1.7K | AMF | ||
| BPIFRANCE INVESTISSEMENT SAStrack record | Sell | $12.1K | AMF | ||
| BPIFRANCE INVESTISSEMENT SAStrack record | Sell | $51K | AMF |